Durvalumab trials for Colorectal cancer

All Durvalumab trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Durvalumab for Colorectal cancer

• Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
  NCT03539822 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
  NCT05845450 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Single cEll pRofiling PErsistaNce To ImmuNothErapy
  NCT06680739 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Durvalumab for Colorectal cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.